About Cure Cancer Australia

 
Cure Cancer Australia Foundation has been funding cancer and leukaemia research programs since it began 41 years ago having funded over 350 researchers.

With the generosity of everyone, the Foundation has been able to support some amazing research scientists at the start of their careers, a time when very little funding is available. This support enables Australia’s brightest research talent to secure further funding, build on their ideas and continue their vital work in Australia. The Foundation have funded grants across all areas of cancer research, including children’s cancers, breast, bowel, skin, prostate, thyroid and bladder cancers and leukaemia.

Thanks to all our donors, our mission is possible: to give young scientists the support they need to pursue potential breakthrough research and ultimately a cure.

Contribute to the cure.

How is Can Too connected to Cure Cancer Australia?

Cure Cancer Australia is proud to have been selected as Can Too’s partner. All of the money raised from Can Too participants goes directly to Cure Cancer Australia to fund cancer research projects. At this time (late 2008) Can Too participants have raised over $2,200,000 for Cure Cancer Australia. Each year, the funds raised for and/or by Cure Cancer Australia go directly to brilliant young researchers to enable them to pursue their potential breakthrough cancer research, for a period of one year. We are only able to achieve this due to the generosity of the Macquarie Bank Foundation, our Principal Supporter.

Can Too have funded the following researchers:

2005    
Bowel Cancer – Dr Megan Hitchins, St Vincent’s Hospital,
2006    
Breast Cancer – Dr Matthew Naylor, Garvin Institute of Medical Research
Skin Cancer – Dr Kirsten Hammond, University of Sydney
Neuroblastoma in Children – Dr Tao Liu, Children’s Cancer Institute of Australia
New Drug Design – Dr Graham Ball, University of NSW
Cell Division in Cancer – Dr Megan Fabbro, Children’s Medical Research Institute
2007    
Cross-Cultural Communication in breast cancer Prognosis – Prof Maurice Eisenbruch, Syd University
Understanding Cancer Behaviour using Proteomic Approaches – Dr Susan Fanayan, APAF, Macquarie University
Ovarian Cancer – Dr Vive Howell, Kolling Institute
Prostrate Cancer – Dr Toby Hulf, Garvin Institute
Control Mechanisms in Cancer – Dr Hugh Morgan, RNS Hospital
Issues Relating to Blood Clotting – Dr Ronald Sluyter, University of Sydney
Strategies to Inhibit Cancer Cell Growth – Dr Shane Thomas, University of NSW
Brain Tumours – Dr Wayne Thomas, Children’s Cancer Institute Australia
2008   
Can Too will be able to fund another 13 researchers


What type of projects does Cure Cancer Australia funding support?

Cure Cancer Australia raises funds through innovative fundraising and with the support of valued corporate and individual donors. To date, more than $8.9 million has been allocated to individual research projects at cancer research institutes, teaching hospitals and university medical faculties in New South Wales, Australia.

The researchers are based in Australia’s leading medical research institutes such as Children’s Cancer Institute Australia, Children’s Medical Research Institute, Garvan Institute of Medical Research, Centenary Institute, Westmead Millennium Institute, Kolling Institute of Medical Research as well as teaching hospitals and university medical faculties.

To read more about Cure Cancer Australia www.cure.org.au